| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
MicroRNAs as a therapeutic target for cardiovascular diseases.
|
J Cell Mol Med
|
2009
|
1.67
|
|
2
|
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.
|
Am J Physiol Renal Physiol
|
2009
|
1.43
|
|
3
|
Folic acid improves inner ear vascularization in hyperhomocysteinemic mice.
|
Hear Res
|
2011
|
1.42
|
|
4
|
Homocysteine causes cerebrovascular leakage in mice.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.35
|
|
5
|
Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.
|
Mol Neurobiol
|
2013
|
1.32
|
|
6
|
Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure.
|
PLoS One
|
2012
|
1.28
|
|
7
|
Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis.
|
J Biol Chem
|
2004
|
1.24
|
|
8
|
H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure.
|
Am J Physiol Heart Circ Physiol
|
2009
|
1.23
|
|
9
|
Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway.
|
Am J Physiol Cell Physiol
|
2005
|
1.22
|
|
10
|
Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.
|
Am J Physiol Cell Physiol
|
2007
|
1.22
|
|
11
|
Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure.
|
J Appl Physiol (1985)
|
2011
|
1.18
|
|
12
|
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.17
|
|
13
|
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.
|
J Appl Physiol (1985)
|
2005
|
1.14
|
|
14
|
Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC.
|
Am J Physiol Heart Circ Physiol
|
2006
|
1.13
|
|
15
|
MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.
|
Arch Physiol Biochem
|
2010
|
1.12
|
|
16
|
MicroRNAs are involved in homocysteine-induced cardiac remodeling.
|
Cell Biochem Biophys
|
2009
|
1.11
|
|
17
|
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
|
Neurochem Int
|
2008
|
1.11
|
|
18
|
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
|
Am J Physiol Renal Physiol
|
2006
|
1.10
|
|
19
|
Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.
|
Am J Physiol Heart Circ Physiol
|
2005
|
1.06
|
|
20
|
Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.
|
J Cell Mol Med
|
2005
|
1.06
|
|
21
|
Hydrogen sulfide protects against vascular remodeling from endothelial damage.
|
Amino Acids
|
2010
|
1.05
|
|
22
|
Homocysteine to hydrogen sulfide or hypertension.
|
Cell Biochem Biophys
|
2010
|
1.05
|
|
23
|
Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid.
|
J Mol Neurosci
|
2014
|
1.03
|
|
24
|
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
|
J Cell Physiol
|
2008
|
1.02
|
|
25
|
Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.
|
Am J Physiol Lung Cell Mol Physiol
|
2010
|
1.01
|
|
26
|
GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells.
|
Cell Biochem Biophys
|
2006
|
1.00
|
|
27
|
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.
|
Am J Physiol Endocrinol Metab
|
2008
|
1.00
|
|
28
|
Cardioprotective role of sodium thiosulfate on chronic heart failure by modulating endogenous H2S generation.
|
Pharmacology
|
2008
|
1.00
|
|
29
|
Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.
|
Mol Neurobiol
|
2013
|
1.00
|
|
30
|
Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.
|
Am J Physiol Cell Physiol
|
2012
|
0.99
|
|
31
|
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
|
Cardiovasc Diabetol
|
2010
|
0.98
|
|
32
|
Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
|
J Cell Biochem
|
2009
|
0.98
|
|
33
|
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
|
Int J Biol Sci
|
2007
|
0.98
|
|
34
|
Fibrinogen-induced endothelin-1 production from endothelial cells.
|
Am J Physiol Cell Physiol
|
2009
|
0.97
|
|
35
|
3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.
|
Am J Physiol Lung Cell Mol Physiol
|
2006
|
0.96
|
|
36
|
Fibrinogen induces alterations of endothelial cell tight junction proteins.
|
J Cell Physiol
|
2009
|
0.95
|
|
37
|
Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.
|
Vasc Health Risk Manag
|
2010
|
0.93
|
|
38
|
GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.
|
Brain Res
|
2008
|
0.93
|
|
39
|
Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice.
|
Mol Cell Biochem
|
2009
|
0.90
|
|
40
|
GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia.
|
J Cell Physiol
|
2005
|
0.89
|
|
41
|
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
|
Int J Biol Sci
|
2008
|
0.89
|
|
42
|
Epigenetic impact of curcumin on stroke prevention.
|
Metab Brain Dis
|
2014
|
0.89
|
|
43
|
Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells.
|
J Cell Physiol
|
2006
|
0.89
|
|
44
|
Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability.
|
J Cell Biochem
|
2012
|
0.87
|
|
45
|
Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.87
|
|
46
|
Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.
|
Am J Physiol Heart Circ Physiol
|
2009
|
0.87
|
|
47
|
Fibrinogen alters mouse brain endothelial cell layer integrity affecting vascular endothelial cadherin.
|
Biochem Biophys Res Commun
|
2011
|
0.85
|
|
48
|
Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics.
|
Int J Physiol Pathophysiol Pharmacol
|
2013
|
0.85
|
|
49
|
The role of homocysteine in bone remodeling.
|
Clin Chem Lab Med
|
2013
|
0.85
|
|
50
|
Homocysteine-induced biochemical stress predisposes to cytoskeletal remodeling in stretched endothelial cells.
|
Mol Cell Biochem
|
2007
|
0.84
|
|
51
|
Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.
|
Arch Physiol Biochem
|
2006
|
0.84
|
|
52
|
Role of PPARgamma, a nuclear hormone receptor in neuroprotection.
|
Indian J Biochem Biophys
|
2011
|
0.84
|
|
53
|
Oxidative remodeling in pressure overload induced chronic heart failure.
|
Eur J Heart Fail
|
2007
|
0.84
|
|
54
|
Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
|
Mol Cell Biochem
|
2012
|
0.83
|
|
55
|
Role of copper and homocysteine in pressure overload heart failure.
|
Cardiovasc Toxicol
|
2008
|
0.83
|
|
56
|
Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.
|
Cell Biochem Biophys
|
2014
|
0.82
|
|
57
|
Differential expression of Gs in a murine model of homocysteinemic heart failure.
|
Vasc Health Risk Manag
|
2009
|
0.82
|
|
58
|
Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in mice.
|
Am J Physiol Heart Circ Physiol
|
2010
|
0.82
|
|
59
|
Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.
|
Int J Physiol Pathophysiol Pharmacol
|
2011
|
0.81
|
|
60
|
Renal mitochondrial damage and protein modification in type-2 diabetes.
|
Acta Diabetol
|
2008
|
0.80
|
|
61
|
Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy.
|
Arch Physiol Biochem
|
2008
|
0.80
|
|
62
|
Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling.
|
Biochem Biophys Res Commun
|
2010
|
0.80
|
|
63
|
Extraoral plasmablastic lymphoma detected using ascitic fluid cytology and flow cytometry: a case report with a review of the literature.
|
Acta Cytol
|
2014
|
0.79
|
|
64
|
Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia.
|
Physiol Rep
|
2014
|
0.78
|
|
65
|
Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
|
Biochem Biophys Res Commun
|
2002
|
0.77
|
|
66
|
Autophagy and heart failure: a possible role for homocysteine.
|
Cell Biochem Biophys
|
2012
|
0.77
|
|
67
|
Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia.
|
Mol Cell Biochem
|
2014
|
0.77
|
|
68
|
C4d FlowPRA is a useful tool in live related renal transplants.
|
Pathology
|
2014
|
0.77
|
|
69
|
Cardiac dys-synchronization and arrhythmia in hyperhomocysteinemia.
|
Curr Neurovasc Res
|
2007
|
0.75
|
|
70
|
Seven novel single nucleotide polymorphisms identified within river buffalo (Bubalus bubalis) lactoferrin gene.
|
Trop Anim Health Prod
|
2009
|
0.75
|
|
71
|
Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus.
|
Antioxid Redox Signal
|
2007
|
0.75
|
|
72
|
Etiology and survival of aplastic anemia: a study based on clinical investigation.
|
J Clin Lab Anal
|
2012
|
0.75
|